BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Worrell SD, Gould TJ. Therapeutic potential of ketamine for alcohol use disorder. Neurosci Biobehav Rev 2021;126:573-89. [PMID: 33989669 DOI: 10.1016/j.neubiorev.2021.05.006] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 Terasaki D, Loh R, Cornell A, Taub J, Thurstone C. Single-dose intravenous ketamine or intramuscular naltrexone for high-utilization inpatients with alcohol use disorder: pilot trial feasibility and readmission rates. Addict Sci Clin Pract 2022;17:64. [DOI: 10.1186/s13722-022-00345-y] [Reference Citation Analysis]
2 Mendes FR, Costa CDS, Wiltenburg VD, Morales-lima G, Fernandes JAB, Filev R. Classic and non‐classic psychedelics for substance use disorder: A review of their historic, past and current research. Addiction Neuroscience 2022;3:100025. [DOI: 10.1016/j.addicn.2022.100025] [Reference Citation Analysis]
3 Martins B, Rutland W, De Aquino JP, Kazer BL, Funaro M, Potenza MN, Angarita GA. Helpful or Harmful? The Therapeutic Potential of Medications with Varying Degrees of Abuse Liability in the Treatment of Substance Use Disorders. Curr Addict Rep. [DOI: 10.1007/s40429-022-00432-9] [Reference Citation Analysis]
4 Joneborg I, Lee Y, Di Vincenzo JD, Ceban F, Meshkat S, Lui LMW, Fancy F, Rosenblat JD, McIntyre RS. Active mechanisms of ketamine-assisted psychotherapy: A systematic review. J Affect Disord 2022:S0165-0327(22)00798-4. [PMID: 35905796 DOI: 10.1016/j.jad.2022.07.030] [Reference Citation Analysis]
5 Amaya F. Sedation, analgesia and withdrawal syndrome in critical care settings. Nihon Shuchu Chiryo Igakukai zasshi 2022;29:269-270. [DOI: 10.3918/jsicm.29_269] [Reference Citation Analysis]
6 Lee YK, Gold MS, Fuehrlein BS. Looking beyond the opioid receptor: A desperate need for new treatments for opioid use disorder. J Neurol Sci 2022;432:120094. [PMID: 34933249 DOI: 10.1016/j.jns.2021.120094] [Reference Citation Analysis]
7 Yan Y, Zhang M, Fan N. Addictions and Polymorphism. Handbook of Substance Misuse and Addictions 2022. [DOI: 10.1007/978-3-030-92392-1_127] [Reference Citation Analysis]
8 Yan Y, Zhang M, Fan N. Addictions and Polymorphism. Handbook of Substance Misuse and Addictions 2022. [DOI: 10.1007/978-3-030-67928-6_127-1] [Reference Citation Analysis]
9 Keeler JL, Treasure J, Juruena MF, Kan C, Himmerich H. Ketamine as a Treatment for Anorexia Nervosa: A Narrative Review. Nutrients 2021;13:4158. [PMID: 34836413 DOI: 10.3390/nu13114158] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
10 Caneparo C, Brownell D, Chabaud S, Bolduc S. Genitourinary Tissue Engineering: Reconstruction and Research Models. Bioengineering (Basel) 2021;8:99. [PMID: 34356206 DOI: 10.3390/bioengineering8070099] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]